| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/31/2002 | CA2418204A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | CA2418199A1 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | CA2416643A1 Ghrelin antagonists |
| 01/31/2002 | CA2412787A1 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide |
| 01/31/2002 | CA2410766A1 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | CA2410682A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/30/2002 | EP1175442A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor |
| 01/30/2002 | EP1175435A1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof |
| 01/30/2002 | EP0904539A4 Inhibiting protein interactions |
| 01/30/2002 | EP0696919B1 Diagnosis and treatment of erectile dysfunction |
| 01/30/2002 | EP0535155B1 Libraries of modified peptides with protease resistance |
| 01/30/2002 | CN1333829A Polypeptide |
| 01/30/2002 | CN1333372A Process for preparing potide zinc easy absorbed in human body |
| 01/30/2002 | CN1078480C Somatostatin binding peptide-metal chelate conjugates |
| 01/29/2002 | US6342383 Reverse transcriptase activity; endogenous retroviruses |
| 01/29/2002 | US6342244 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides, drugs and liposomes; upon cleavage of the linkage, the ligand |
| 01/29/2002 | US6342201 Complex compounds for diagnosis of vascular diseases |
| 01/29/2002 | CA1341336C Neuropeptide y agonists |
| 01/24/2002 | WO2002006308A2 Methods for promoting dendritic cell proliferation or differentiation |
| 01/24/2002 | WO2002006306A2 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 01/24/2002 | WO2002005838A1 Derivatives of laspartomycin and preparation and use thereof |
| 01/24/2002 | WO2002005837A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| 01/24/2002 | WO2001070767A3 Therapeutic anti-melanoma compounds |
| 01/24/2002 | WO2001025397A3 Compositions and methods for tumor-targeted delivery of effector molecules |
| 01/24/2002 | WO2001015511A3 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 01/24/2002 | WO2001000655A3 Therapeutic peptides derived from subsequences of bpi |
| 01/24/2002 | US20020010134 Peptide compositions mimicking tgf-beta activity |
| 01/24/2002 | US20020009756 Biosynthesis of amino acid sequences; assign value to peptides, rearrange peptides according to numerical value, graph values, synthesize preferential peptide |
| 01/24/2002 | US20020009752 Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof |
| 01/24/2002 | US20020009491 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 01/24/2002 | CA2450747A1 Derivatives of laspartomycin and preparation and use thereof |
| 01/24/2002 | CA2450372A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| 01/24/2002 | CA2410898A1 Substrates and assays for .beta.-secretase activity |
| 01/23/2002 | EP1174439A2 Compositions and methods for treating infections using analogues of indolicidin |
| 01/23/2002 | EP1173767A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/23/2002 | EP1173480A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 01/23/2002 | EP1173473A1 Antifungal agents isolated from pseudomonas syringae |
| 01/23/2002 | EP1173472A1 Cyclic hexapeptides having antibiotic activity |
| 01/23/2002 | EP1173471A2 Pseudomycin analogs |
| 01/23/2002 | EP1173469A2 Adhesion modulatory peptides and methods for use |
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP1173222A2 Conjugate having a cleavable linkage for use in a liposome |
| 01/23/2002 | EP0815122B1 Process for preparation of pure cyclosporin chromatographically using an eluent consisting essentially of high pressure carbon dioxide |
| 01/23/2002 | EP0797590B1 Neurotrophic peptides of activity dependent neurotrophic factor |
| 01/23/2002 | EP0745093B1 New oligopeptides with affinity to opioid receptors |
| 01/23/2002 | EP0623144B1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 01/23/2002 | CN1332635A Controlled release formulation comprising GnRH-II |
| 01/22/2002 | CA2107556C Increasing blood-brain barrier permeability with permeabilizer peptides |
| 01/22/2002 | CA2057711C Antibiotic agent |
| 01/22/2002 | CA2038848C Hydantoin derivatives |
| 01/22/2002 | CA1341334C Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
| 01/22/2002 | CA1341333C Amylin peptides and uses thereof |
| 01/17/2002 | WO2002004497A2 Multiple antigenic peptides immunogenic against streptococcus pneumoniae |
| 01/17/2002 | WO2002004482A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 01/17/2002 | WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 01/17/2002 | WO2001046222A3 Peptides designed for the diagnosis and treatment of rheumatoid arthritis |
| 01/17/2002 | WO2001046125A3 Cd45 inhibitors |
| 01/17/2002 | US20020006898 Trimethyl lock based tetrapartate prodrugs |
| 01/17/2002 | US20020006671 Luminescence polarization assays |
| 01/17/2002 | CA2416224A1 Multiple antigenic peptides immunogenic against streptococcus pneumoniae |
| 01/17/2002 | CA2415179A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 01/16/2002 | EP1172441A1 A promoter derived from phytosulfokine precursor gene |
| 01/16/2002 | EP1172373A2 Method for preparing zinc-oligopeptide easily absorbable by the human body |
| 01/16/2002 | EP1171612A2 Telomerase-specific cancer vaccine |
| 01/16/2002 | EP1171598A2 Peptides and the use thereof to control pests |
| 01/16/2002 | EP1171582A2 Long lasting anti-angiogenic peptides |
| 01/16/2002 | EP1171576A1 PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE) |
| 01/16/2002 | EP1171453A2 Materials and methods useful for the control of insect larvae |
| 01/16/2002 | EP1171152A1 vMIP-II PEPTIDE ANTAGONISTS OF CXCR4 |
| 01/16/2002 | EP1170998A2 Transformed cells useful for the control of pests |
| 01/16/2002 | EP1019095B1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
| 01/16/2002 | EP0932617B1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 01/16/2002 | CN1331083A Memory-improving peptides and their application |
| 01/16/2002 | CN1077800C Cyclosporin soft capsule compsn. |
| 01/15/2002 | US6339149 Isolated nucleic acid molecules which encode tumor rejection antigens found in dage |
| 01/15/2002 | US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate |
| 01/15/2002 | CA2022444C Lhrh analogs |
| 01/10/2002 | WO2002002628A1 Novel gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same |
| 01/10/2002 | WO2002002596A2 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 01/10/2002 | WO2002002595A1 Amphipathic linear peptides and compositions containing same |
| 01/10/2002 | WO2002002594A1 Peptide for swine pregnancy test reagents and swine pregnancy test reagents |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002592A1 Memory-enhancing peptides and the use thereof |
| 01/10/2002 | WO2002002591A2 Peptides for use in culture media |
| 01/10/2002 | WO2002002488A2 Methods and compounds for modulating nuclear receptor coactivator binding |
| 01/10/2002 | WO2002002147A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | WO2002002133A2 Peptide composition for treatment of periodontal diseases and prevention of skin aging |
| 01/10/2002 | WO2001070930A3 Growth factor binding molecules |
| 01/10/2002 | WO2001052900A3 Novel orthogonally protected amino acid chelators for biomedical applications |
| 01/10/2002 | WO2001049708A3 Peptide ligands that mimic sensor kinases and inhibit response regulators |
| 01/10/2002 | WO2001036452A3 Heteroclitic analogs of class i epitodes |
| 01/10/2002 | US20020004485 Administering oligopeptide |
| 01/10/2002 | US20020004479 Biodegradable inserts |
| 01/10/2002 | US20020004247 Assay method |
| 01/10/2002 | CA2415103A1 Methods and compounds for modulating nuclear receptor coactivator binding |
| 01/10/2002 | CA2414650A1 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 01/10/2002 | CA2414635A1 Novel gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same |
| 01/10/2002 | CA2414355A1 Amphipathic linear peptides and compositions containing same |
| 01/10/2002 | CA2412836A1 Peptide composition for treatment of periodontal diseases and prevention of skin aging |
| 01/09/2002 | EP1170300A1 Method for modification of recombinant polypeptides |